HomepageEarnings Events Newsdesk 1 hour ago Boston Scientific Corp (BSX) HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism Boston Scientific Corp (NYSE: BSX) FY 2026 Other Release Boston Scientific Corp (BSX) CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints » « Steel Dynamics, Inc (STLD) Sec Form 8K Newsdesk:
